Flow Cytometry Facility (Larry W. Arnold, Ph.D., Facility Director) The Flow Cytometry Facility provides Cancer Center investigators with access to all aspects of flow cytometry technology, including state-of-the- art instrumentation, data acquisition, high speed cell sorting, data analysis, preparation of publication-quality data presentation, and consultation. Facility staff also train users to prepare samples and operate the analytical flow cytometers (B-D FACScans) and one sorting flow cytometer (Cytomation MoFlo), which has added high-speed cell sorting capabilities to the facility array of services. Over the past year, there has been a large increase in flow cytometry use, with a significant increase in sorting as the MoFlo became operational. In fiscal year 1997-1998, the facility charged for 2,851 hours of use. Cancer Center members accounted for more than three-fourths (79%) of all this use, while the Center Core Support Grant (CCSG) constituted just under one-half (49%) of the budget. All of the Cancer Center use was by investigators with peer- reviewed funding. In the coming year, CCSG support of $75,992 is requested (43% of total budget), primarily to support the Facility Director (35%) and technician (75%), who have played a central role in promoting increased use overall as well as of sorting flow cytometry. Because service contracts for flow cytometry equipment are considerable, CCSG support for one-third ($20,000) of the facility's service contract costs is also requested.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-25
Application #
6398589
Study Section
Project Start
2000-05-01
Project End
2000-11-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Suzuki, Aussie; Long, Sarah K; Salmon, Edward D (2018) An optimized method for 3D fluorescence co-localization applied to human kinetochore protein architecture. Elife 7:
Mohan, Vishwa; Sullivan, Chelsea S; Guo, Jiami et al. (2018) Temporal Regulation of Dendritic Spines Through NrCAM-Semaphorin3F Receptor Signaling in Developing Cortical Pyramidal Neurons. Cereb Cortex :
Haase, Karen P; Fox, Jaime C; Byrnes, Amy E et al. (2018) Stu2 uses a 15-nm parallel coiled coil for kinetochore localization and concomitant regulation of the mitotic spindle. Mol Biol Cell 29:285-294
Nicholls, Thomas J; Nadalutti, Cristina A; Motori, Elisa et al. (2018) Topoisomerase 3? Is Required for Decatenation and Segregation of Human mtDNA. Mol Cell 69:9-23.e6
Becker, Silke; Wang, Haibo; Simmons, Aaron B et al. (2018) Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms. Sci Rep 8:2003
Kim, R D; Alberts, S R; Peña, C et al. (2018) Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer. Br J Cancer 118:462-470
Chiang, Yun-Chen; Park, In-Young; Terzo, Esteban A et al. (2018) SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. Cancer Res 78:3135-3146
Reuland, Daniel S; Cubillos, Laura; Brenner, Alison T et al. (2018) A pre-post study testing a lung cancer screening decision aid in primary care. BMC Med Inform Decis Mak 18:5
Kornides, Melanie L; McRee, Annie-Laurie; Gilkey, Melissa B (2018) Parents Who Decline HPV Vaccination: Who Later Accepts and Why? Acad Pediatr 18:S37-S43
Ramsingh, Arlene I; Gray, Steven J; Reilly, Andrew et al. (2018) Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation. PLoS One 13:e0198154

Showing the most recent 10 out of 1525 publications